48 week bone marker changes with Dolutegravir (DTG) plus Abacavir/Lamivudine (ABC/3TC) vs. Tenofovir/Emtricitabine/Efavirenz (EFV/TDF/FTC): the SINGLE trial

by Yazdanpanah, Y, Khuong-Josses, M-A, Hocqueloux, L, Pialoux, G, Durant, J, Wynne, B, Granier, C, Tebas, P, Pappa, K, Min, S
Published 2014

Mitral endocarditis due to Rothia aeria with cerebral haemorrhage and femoral mycotic aneurysms, first French description

by Collarino, R., Vergeylen, U., Emeraud, C., Latournèrie, G., Grall, N., Mammeri, H., Messika-Zeitoun, D., Vallois, D., Yazdanpanah, Y., Lescure, F.-X., Bleibtreu, A.
Published 2016

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study

by Raben, D., Mocroft, A., Rayment, M., Mitsura, V. M., Hadziosmanovic, V., Sthoeger, Z. M., Palfreeman, A., Morris, S., Kutsyna, G., Vassilenko, A., Minton, J., Necsoi, C., Estrada, V. P., Grzeszczuk, A., Johansson, V. Svedhem, Begovac, J., Ong, E. L. C., Cabié, A., Ajana, F., Celesia, B. M., Maltez, F., Kitchen, M., Comi, L., Dragsted, U. B., Clumeck, N., Gatell, J., Gazzard, B., d’Arminio Monforte, A., Rockstroh, J., Yazdanpanah, Y., Champenois, K., Jakobsen, M. L., Sullivan, A., Lundgren, J. D.
Published 2015